| Literature DB >> 25961831 |
Henglong Hu1, Baolong Qin1, Deng He1, Yuchao Lu1, Zhenyu Zhao1, Jiaqiao Zhang1, Yufeng Wang1, Shaogang Wang1.
Abstract
OBJECTIVE: To compare the effectiveness and safety of regional anesthesia (RA) and general anesthesia (GA) for percutaneous nephrolithotomy (PNL). PATIENTS AND METHODS: PubMed, EMBASE, The Cochrane Library, and the Web of Knowledge databases were systematically searched to identify relevant studies. After literature screening and data extraction, a meta-analysis was performed using the RevMan 5.3 software.Entities:
Mesh:
Year: 2015 PMID: 25961831 PMCID: PMC4427359 DOI: 10.1371/journal.pone.0126587
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1(A) Flowchart of the studies selection process.
(B) Funnel plot of operative time.
Characteristics and methodological quality of included studies.
| Study | Year | Study design | Level of evidence | Study quality | Anesthesia technique | Sample size | Age(year) (M±SD) | Sex (M/F) | BMI | ASA score | Stone area or maximal diameter |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Elbealy [ | 2008 | RCT | Level 2 | 3/5 | RA(EA) | 19 | 41±13 | 19/0 | 28.1 | Ⅰ15 Ⅱ5 Ⅲ0 | ND |
| GA | 20 | 39±15 | 20/0 | 27.4 | Ⅰ15 Ⅱ5 Ⅲ0 | ND | |||||
| Karacalar [ | 2009 | RCT | Level 2 | 3/5 | RA(CSEA) | 86 | 48.64±16 | 45/41 | 27.6±7.2 | Ⅰ35 Ⅱ51 Ⅲ0 | 1137.78mm2 |
| GA | 90 | 48.32±15 | 47/43 | 27.8±6.2 | Ⅰ37 Ⅱ53 Ⅲ0 | 598.4mm2 | |||||
| Singh [ | 2011 | RCT | Level 2 | 3/5 | RA(CSEA) | 32 | 40.06±13.41 | 22/10 | ND | ND | 2195.31±643mm2 |
| GA | 32 | 39.66±13.7 | 18/14 | ND | ND | 2271±620mm2 | |||||
| Tangpaitoon [ | 2012 | RCT | Level 2 | 3/5 | RA(EA) | 24 | 53.04±13.53 | 17/7 | 21.25±3.21 | Ⅰ10 Ⅱ13 Ⅲ1 | 40.8 ± 16.4mm |
| GA | 26 | 56.69±11.32 | 16/10 | 21.36±3.98 | Ⅰ7 Ⅱ18 Ⅲ1 | 35.4 ± 15.0mm | |||||
| Mehrabi [ | 2013 | RCT | Level 2 | 3/5 | RA(SA) | 58 | 47.4±7.6 | 31/27 | 24.1±7.2 | all<Ⅲ | 32.8 ± 9.6mm |
| GA | 52 | 43.7±8.2 | 35/17 | 24.1±5.6 | all<Ⅲ | 30.9 ± 10.6mm | |||||
| Nouralizadeh [ | 2013 | RCT | Level 2 | 3/5 | RA(SA) | 50 | 41.16±11.2 | 29/21 | ND | ND | 55.1±28.7mm |
| GA | 50 | 42.66±13.61 | 27/23 | ND | ND | 55.6±29.5mm | |||||
| Movasseghi [ | 2014 | RCT | Level 2 | 3/5 | RA(SA) | 29 | 39.6±9.7 | 19/10 | 26.4±3.8 | Ⅰ23 Ⅱ6 Ⅲ0 | ND |
| GA | 30 | 46.9±13.6 | 19/11 | 28.1±4.6 | Ⅰ22 Ⅱ8 Ⅲ0 | ND | |||||
| Moawad [ | 2015 | RCT | Level 2 | 2/5 | RA(SA) | 100 | 44±11 | 60/40 | 27.1±4.1 | Ⅰ65 Ⅱ35 Ⅲ0 | 31.9±7.4mm |
| GA | 100 | 43±11 | 64/36 | 27.4±2.1 | Ⅰ69 Ⅱ31 Ⅲ0 | 33.7±6.3mm | |||||
| Kuzgunbay [ | 2009 | CS | Level 3 | 8/9 | RA(CSEA) | 37 | 44±15 | 24/13 | ND | ND | 731±394mm2 |
| GA | 45 | 45±15 | 26/19 | ND | ND | 734±386mm2 | |||||
| Kim [ | 2013 | CS | Level 3 | 9/9 | RA(CSEA) | 77 | 54.8±12.2 | 47/30 | 25.1±3.9 | ND | 34.5±24.0mm |
| GA | 24 | 50.8±17.8 | 14/10 | 23.3±2.8 | ND | 42.3±36.1mm | |||||
| Moslemi [ | 2013 | CS | Level 3 | 8/9 | RA(SA/EA) | 54 | 39 | ND | 25 | ⅠandⅡ59 Ⅲ5 | ND |
| GA | 69 | 41 | ND | 26 | ⅠandⅡ55 | ND | |||||
| Cicek [ | 2014 | CS | Level 3 | 8/9 | RA(SA) | 440 | 48.8±14.03 | 283/157 | ND | Ⅰ238Ⅱ169Ⅲ33 | 533.9±480.94mm2 |
| GA | 564 | 47.2±13.83 | 344/220 | ND | Ⅰ305Ⅱ218Ⅲ39 | 529.5±324.12mm2 | |||||
| Gonen [ | 2014 | CS | Level 3 | 9/9 | RA(SA) | 29 | 45.6±13.6 | 18/8 | ND | ND | 558.6±297.2mm2 |
| GA | 20 | 40.8±12.9 | 13/7 | ND | ND | 630.7±486.2mm2 | |||||
| Karatag [ | 2015 | CS | Level 3 | 7/9 | RA(SA) | 63 | 45.8±14.6 | ND | 27.0±4.9 | ND | 155.08±84.9mm2 |
| GA | 53 | 30.3±22.1 | ND | 25.8±7.1 | ND | 151.00±75.5mm2 |
BMI: body mass index ASA: American Society of Anesthesiologists RCT: randomized controlled trial RA: regional anesthesia EA: epidural anesthesia ND: not demonstrated GA: general anesthesia CSEA: combined spinal epidural anesthesia SA: spinal anesthesia CS: cohort study
* Originally twenty patients included in the RA group, but one patient converted to GA.
**Totally 69 patients were included in the GA group, the authors [16] might report a wrong number here.
Fig 2Forest plots and meta-analyses of (A) operative time, (B) hospital stay and (C) stone-free rate.
Fig 3Forest plots and meta-analyses of (A) VAS on the 1st, 2nd and 3rd postoperative day, and (B) analgesic requirement.
Fig 4Forest plots and meta-analyses of intraoperative hypotension, nausea and/or vomiting, fever and blood transfusion.
Fig 5Forest plot and meta-analyses of postoperative complications.
Sensitivity analysis results.
| Items | Studies | Sample size | Tests for heterogeneity | Analysis model | Test for overall effect | RR/WMD | Favors | ||
|---|---|---|---|---|---|---|---|---|---|
| RA/GA | I2 | P | Z | P | 95%CI | ||||
| Operative Time(min) | [ | 398/400 | 85% | <0.00001 | Random | 2.63 | 0.009 | -5.55 [-9.68,-1.41] | RA |
| Tramadol demand(mg) | [ | 345/344 | 96% | <0.00001 | Random | 5.64 | <0.00001 | -59.68 [-80.41,-38.94] | RA |
| Complications | |||||||||
| IOH | [ | 144/142 | 41% | 0.19 | Fixed | 2.56 | 0.01 | 2.24 [1.21,4.15] | GA |
| Nausea/Vomiting | [ | 318/318 | 0% | 0.92 | Fixed | 4.23 | <0.0001 | 0.39 [0.25,0.60] | RA |
| Fever | [ | 194/192 | 5% | 0.35 | Fixed | 1.30 | 0.19 | 0.75 [0.48,1.16] | RA |
| Blood Transfusion | [ | 193/190 | 0% | 0.85 | Fixed | 0.36 | 0.72 | 0.90 [0.52,1.56] | RA |
| Grade I POC | [ | 132/128 | 46% | 0.16 | Fixed | 0.88 | 0.38 | 0.69 [0.30,1.58] | RA |
| Grade II POC | [ | 132/128 | 0% | 0.99 | Fixed | 0.56 | 0.58 | 0.85 [0.48,1.50] | RA |
| ≥Grade III POC | [ | 108/102 | 0% | 0.78 | Fixed | 1.09 | 0.27 | 0.44 [0.10,1.91] | RA |
| Total POC | [ | 132/128 | 5% | 0.35 | Fixed | 1.45 | 0.15 | 0.74 [0.49,1.11] | RA |
| Hospital Stay(d) | [ | 192/198 | 49% | 0.12 | Fixed | 7.73 | <0.00001 | -0.59[-0.74,-0.44] | RA |
| Stone-Free Rate | [ | 234/182 | 0% | 0.48 | Fixed | 0.42 | 0.68 | 1.02 [0.93,1.12] | RA |
RA: regional anesthesia GA: general anesthesia RR: relative risk WMD: weighted mean difference CI: confidence interval IOH: intraoperative hypotension POC: postoperative complications
* P<0.05 was considered statistically significant.
**originally significant before nRCTs excluded.